𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Considerations for the use of testosterone with systemic chemotherapy in prostatic cancer

✍ Scribed by Jackson E. Fowler Jr.; Willet F. Whitmore Jr.


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
445 KB
Volume
49
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Use of neuroendocrine serum markers in t
✍ Angelsen, Anders; Syversen, Unni; Stridsberg, Mats; Haugen, Olav A.; MjΓΈlnerΓΈd, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 274 KB πŸ‘ 2 views

Neuroendocrine (NE) differentiation of prostatic adenocarcinomas has received increasing attention in recent years as a result of possible implications on prognosis and therapy. The incidence of NE cells in tumors has been reported from 10% up to 100%. Several studies have shown chromogranin A (CgA)

Bioimpedance: Novel use of a minimally i
✍ Lee, Benjamin R.; Roberts, William W.; Smith, Dexter G.; Ko, Harvey W.; Epstein, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 235 KB πŸ‘ 2 views

## Background: Prostate cancer is presently diagnosed by transrectal ultrasound (trus)-guided sextant needle biopsy. while echo texture of the tissue can prompt localization of tumor, it is presently imprecise. from 50-75% of men biopsied, based on an abnormal digital rectal examination (dre) or el

Correlation of the osteoblastic phenotyp
✍ Doherty, Alan; Smith, Gillian; Banks, Linda; Christmas, Timothy; Epstein, Richar πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 216 KB πŸ‘ 2 views

The characteristic sclerotic appearance of bone metastases from prostate cancer is unexplained but could involve excess peritumoural activity of osteoblast mitogens such as the insulin-like growth factors (IGFs). Since prostatic metastases are distinguished by androgen-dependent secretion of prostat